What Is Still Unknown There are still many things that doctors and scientists do not know about tirzepatide and breastfeeding
Strictly For Intravenous Use by Professionals This medication is formulated exclusively for intravenous (IV) administration, ensuring rapid absorption and optimal effect
Contrave The findings of the COR-BMOD trial found that, after 56 weeks, participants taking Contrave lost an average of 8.1% of their initial body weight, while the placebo group lost only 4.9%
Evidence snapshot: The article cites a 2025 randomized, placebo-controlled trial (reduced cravings and heavy drinking), a 2024 real-world cohort (lower AUD risk with semaglutide), and expert reviews calling the data promising but preliminary
Inject at a time when you have light meals planned (breakfast or early afternoon rather than late evening), allowing you to observe your appetite response during waking hours